Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 287

The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.

Current cancer burden in China: epidemiology, etiology, and prevention

Open access
Cao, Maomao, Li, He, Sun, Dianqin, He, Siyi, Yan, Xinxin, Yang, Fan, Zhang, Shaoli, Xia, Changfa, Lei, Lin, Peng, Ji, Chen, Wanqing·2022·Cancer Biology & Medicine

Abstract

Cancer has become the most common cause of death in China. Owing to rapid economic development, improved livelihood, and shifts in risk factors, cancer epidemiology has experienced substantial changes during the past several decades. In this review, we aim to describe the current cancer epidemiology of the main types of cancer in China, report major risk factors associated with cancer development, and summarize the contributions of the Chinese government to controlling the cancer burden. A total of 4,064,000 new cases were diagnosed in China in 2016. The most frequent types are lung cancer (828,100; 20.4%), colorectal cancer (408,000; 10.0%), and gastric cancer (396,500; 9.8%). Lung (657,000; 27.2%), liver (336,400, 13.9%), and stomach (288,500; 12.0%) cancers are the 3 most deadly cancers in the general population. The 5-year survival rate for cancer has dramatically increased in recent decades. However, liver and particularly pancreatic cancers still have the poorest prognosis. The main modifiable risk factors associated with cancer development include infectious agents, smoking, alcohol consumption, obesity, unhealthful dietary habits, and inadequate physical activity. The Chinese government has made unremitting efforts to decrease the cancer burden, including cancer education and investment in cancer screening programs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.20892/j.issn.2095-3941.2022.0231

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 83 references

Cited by

See all 287

Metadata

Authors
Cao, M., Li, H., Sun, D., He, S., Yan, X., Yang, F., Zhang, S., Xia, C., Lei, L., Peng, J., & Chen, W.
Venue
Cancer Biology & Medicine
Published
2022-08-15
Volume
19
Issue
8
Pages
1121-1138
ISSN
2095-3941 (ISSN-L)
OpenAlex
W4294754570
Cited by
287
References
83
FWCI
21.84
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Current cancer burden in China: epidemiology, etiology, and prevention. https://app.cochat.ai/papers/10.20892/j.issn.2095-3941.2022.0231
The paper
Cao, M., Li, H., Sun, D., He, S., Yan, X., Yang, F., Zhang, S., Xia, C., Lei, L., Peng, J., & Chen, W. (2022). Current cancer burden in China: epidemiology, etiology, and prevention. Cancer Biology & Medicine. https://doi.org/10.20892/j.issn.2095-3941.2022.0231

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.